Delivery Order SPE2DB22D6029-SPE2DB25FLWAK
- Not listed
- The Defense Logistics Agency awarded a $1,176.60 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol Valerate 200 mg/5 ml in 5 ml vials, with a completion date of June 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Depo-Estradiol 5 mg/mL vial, a medication used for various medical conditions. The contract has a ceiling value of $1,747.92 and is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,452 firm-fixed-price delivery order is for the supply of DEPO-ESTRADIOL 5 MG/ML VIAL 5ML, with a period of performance through March 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,580.94 to supply Depo-Estradiol 5 mg/ml vial 5ml. The contract has a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol Valerate 100 mg/5 mL (5 mL vials) on September 4, 2025, with a ceiling value of $1,154.10. This firm fixed-price delivery order is non-competitive and represents a single shipment under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract completion date is set for September 5, 2025, with performance to be fulfilled from...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,602.53 to AmerisourceBergen Drug Corp for Estradiol 10 MCG Vaginal Insert (18-unit package) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction supporting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,251.69 Firm Fixed Price delivery order is for the supply of Depo-Estradiol 5 mg/ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of...
- The Defense Logistics Agency awarded a $2,676.81 delivery order to AmerisourceBergen Drug Corp for 42.5 grams of Estradiol 0.01% cream on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,211.59 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Estradiol 0.01% cream in 42.5-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLWAKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,054.83 to AmerisourceBergen Drug Corp for Depo-Estradiol 5 mg/ml vials (5 ml) on September 17, 2025, with a completion date of September 18, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems globally. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive award processes. The company's primary IDC with DLA functions as a comprehensive global pharmaceutical support vehicle, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for hormone treatment medication supports the Defense Health Agency and other federal healthcare systems' ongoing medical supply needs. AmerisourceBergen's contract awards consistently feature firm fixed pricing structures and reflect the company's versatility in managing transactions ranging from modest orders to substantial multi-million-dollar commitments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/17/25 |